Cargando…

A nomogram for predicting postoperative overall survival of patients with lung squamous cell carcinoma: A SEER-based study

BACKGROUND: Lung squamous cell carcinoma (LSCC) is a common subtype of non-small cell lung cancer. Our study aimed to construct and validate a nomogram for predicting overall survival (OS) for postoperative LSCC patients. METHODS: A total of 8,078 patients eligible for recruitment between 2010 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Jin, Yu, Yue, Zhang, Li, Wang, Xuefu, Wang, Pei, Wang, Zhinong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118027/
https://www.ncbi.nlm.nih.gov/pubmed/37091268
http://dx.doi.org/10.3389/fsurg.2023.1143035
Descripción
Sumario:BACKGROUND: Lung squamous cell carcinoma (LSCC) is a common subtype of non-small cell lung cancer. Our study aimed to construct and validate a nomogram for predicting overall survival (OS) for postoperative LSCC patients. METHODS: A total of 8,078 patients eligible for recruitment between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database. Study outcomes were 1-, 2- and 3-year OS. Analyses performed included univariate and multivariate Cox regression, receiver operating characteristic (ROC) curve construction, calibration plotting, decision curve analysis (DCA) and Kaplan–Meier survival plotting. RESULTS: Seven variables were selected to establish our predictive nomogram. Areas under the ROC curves were 0.658, 0.651 and 0.647 for the training cohort and 0.673, 0.667 and 0.658 for the validation cohort at 1-, 2- and 3-year time-points, respectively. Calibration curves confirmed satisfactory consistencies between nomogram-predicted and observed survival probabilities, while DCA confirmed significant clinical usefulness of our model. For risk stratification, patients were divided into three risk groups with significant differences in OS on Kaplan–Meier analysis (P < 0.001). CONCLUSION: Here, we designed and validated a prognostic nomogram for OS in postoperative LSCC patients. Application of our model in the clinical setting may assist clinicians in evaluating patient prognosis and providing highly individualized therapy.